Related Experiment Videos
Caspase-3 activation in oligodendrocytes from the myelin-deficient rat
J S Beesley1, L Lavy, N B Eraydin
1Department of Neurology Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. beesley@email.chop.edu
Abstract:
The myelin-deficient (MD) rat has a point mutation in its proteolipid protein (PLP) gene that causes severe dysmyelination and oligodendrocyte cell death. Using an in vitro model, we have shown that MD oligodendrocytes initially differentiate similarly to wild-type cells, expressing galactocerebroside, 2',3'-cyclic nucleotide 3'-phosphodiesterase, and myelin basic protein. However, at the time when PLP expression would normally begin, the MD oligodendrocytes die via an apoptotic pathway involving caspase activation. The active form of caspase-3 was detected, along with the cleavage products of poly-(ADP-ribose) polymerase (PARP) and spectrin, major targets of caspase-mediated proteolysis. A specific inhibitor of casapse-3, Ac-DEVD-CMK, reduced apoptosis in MD oligodendrocytes, but the rescued cells did not mature fully or express myelin-oligodendrocyte glycoprotein. These results suggest that mutant PLP affects not only cell death but also oligodendrocyte differentiation.
Insights
Myelin-deficient rat oligodendrocytes undergo apoptosis due to a proteolipid protein (PLP) gene mutation. Inhibiting caspase-3 reduced cell death but did not restore full oligodendrocyte differentiation.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- The myelin-deficient (MD) rat exhibits dysmyelination and oligodendrocyte death due to a proteolipid protein (PLP) gene mutation.
- Oligodendrocytes are crucial for myelin sheath formation in the central nervous system.
Purpose of the Study:
- To investigate the molecular mechanisms underlying oligodendrocyte cell death in MD rats.
- To determine the role of mutant PLP in oligodendrocyte apoptosis and differentiation.
Main Methods:
- Utilized an in vitro model of MD rat oligodendrocytes.
- Analyzed oligodendrocyte differentiation markers (galactocerebroside, 2',3'-cyclic nucleotide 3'-phosphodiesterase, myelin basic protein, myelin-oligodendrocyte glycoprotein).
- Assessed apoptosis via caspase activation, including caspase-3, and cleavage of PARP and spectrin. Employed a caspase-3 inhibitor (Ac-DEVD-CMK).
Main Results:
- MD oligodendrocytes initially differentiate normally but undergo apoptosis upon attempted PLP expression.
- Caspase-3 activation and cleavage of PARP and spectrin were observed, indicating an apoptotic pathway.
- Caspase-3 inhibition reduced apoptosis but did not rescue full differentiation, with myelin-oligodendrocyte glycoprotein expression remaining low.
Conclusions:
- Mutant proteolipid protein (PLP) triggers apoptosis in oligodendrocytes.
- The PLP mutation impacts both oligodendrocyte cell death and their ability to fully differentiate and express myelin components.